Results 261 to 270 of about 802,617 (317)
Some of the next articles are maybe not open access.

Leukemia in childhood

The Indian Journal of Pediatrics, 1962
Twelve cases of leukemia (nine acute, three chronic) treated from December, 1960 to August, 1962 are presented. Clinical features, course of illness and therapy are discussed in relation to the Indian literature. The average survival period of acute leukemia was 39 weeks (range 1–20 months). nt]mis|From The Department of Pediatrics, All-India Institute
O P, GHAI, S K, KHATRAPAL, B N, WALIA
openaire   +2 more sources

Leukemia in infants

The Indian Journal of Pediatrics, 2002
Acute Leukemia is rare in infants. It is characterized by non-specific symptomatology requiring a high index of suspicion on the part of a pediatrician for referral and diagnosis. It has peculiar biological features, unresponsiveness to treatment and poor prognosis.Eighteen infants with acute leukemia were seen during 1994 to 2001 and were analyzed on ...
Saika, Somjee   +10 more
openaire   +2 more sources

Leukemia vaccines

Current Oncology Reports, 2001
Leukemia is susceptible to immune-mediated therapies such as allogeneic stem-cell transplantation, donor lymphocyte infusion, and interferon. The clinical effectiveness of these immune-based modalities has encouraged interest in vaccine therapies for leukemia.
J N, Kochenderfer, J J, Molldrem
openaire   +2 more sources

Autophagy and Leukemia

2020
Leukemia is a malignant clonal disease that originates from hematopoietic stem cells. As in-depth research examines the molecular biology and immunology of the hematopoietic system, leukemia treatment has evolved from a single cytotoxic drug to treatments that inducing differentiation and apoptosis.
Zhong, Zheng   +4 more
openaire   +2 more sources

Neuroimaging in Leukemia

Hematology/Oncology Clinics of North America, 2016
Leukemias are a heterogeneous group of hematologic malignancies that results from uncontrolled neoplastic proliferation of undifferentiated or partially differentiated hematopoietic cells. Patients with acute leukemia can have a variety of craniocerebral complications, which can result from direct leukemic involvement, secondary to cerebrovascular or ...
Seyed Ali, Nabavizadeh   +2 more
openaire   +2 more sources

Myelodysplasia and the leukemias

Current Problems in Cancer, 1997
The armistice after World War II marked the beginning of an era that was to last to the end of the present century. It was an era in which many changes in medicine and nursing combined to alter the entire philosophy of managing malignant disease. More specifically, the fluid-phase tumors, which comprise myelodysplasia and the leukemias, were singled ...
openaire   +2 more sources

The anemia of leukemia

The American Journal of Medicine, 1960
Abstract The pathogenetic mechanisms, clinical manifestations and treatment of anemia in the various forms of leukemia is discussed. Cases are cited to illustrate "preleukemic" hypoplasia of the bone marrow and abnormalities of the red cells encountered in patients with leukemia and with myeloid metaplasia. Particular reference is made to the role of
S B, TROUP, S N, SWISHER, L E, YOUNG
openaire   +2 more sources

Hypokalemia in Leukemia

Annals of Internal Medicine, 1977
Excerpt To the editor: I am writing with regard to the comments made by Dr. Yeung and Dr. Trowbridge (1) on hypokalemia in the blastic crisis of chronic granulocytic leukemia.
D, Prager, J, Rule, H, Kintzi
openaire   +2 more sources

Hypoglycemia and Leukemia

Pediatrics, 1972
I read with interest the report1 by Drs. Jaffe and Kim regarding hypoglycemia in a child with acute myelogenous leukemia. I should like to call to your attention our reports2,3 describing reduced liver-glucose-6-phosphatase in children with leukemia.
openaire   +2 more sources

Leukemia Vaccines

Acta Haematologica, 2003
Evidence that immunological effector mechanisms contribute to the elimination of leukemic blasts in allogeneic bone marrow transplantation supports the concept that the immune system plays a prominent role in the control of leukemic disease. For patients with high-risk acute leukemia, relapse prevention in the setting of minimal residual disease is ...
Ludmila, Glouchkova   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy